UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000017573
Receipt number R000020363
Scientific Title S-1(DGS), nedaplatin, and cetuximab chemotherapy for advanced or recurrent head and neck cancer: a phase I/II study.
Date of disclosure of the study information 2015/05/15
Last modified on 2016/11/14 19:39:54

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

S-1(DGS), nedaplatin, and cetuximab chemotherapy for advanced or recurrent head and neck cancer: a phase I/II study.

Acronym

S-1(DGS), nedaplatin, and cetuximab chemotherapy for advanced or recurrent head and neck cancer: a phase I/II study.

Scientific Title

S-1(DGS), nedaplatin, and cetuximab chemotherapy for advanced or recurrent head and neck cancer: a phase I/II study.

Scientific Title:Acronym

S-1(DGS), nedaplatin, and cetuximab chemotherapy for advanced or recurrent head and neck cancer: a phase I/II study.

Region

Japan


Condition

Condition

advanced or recurrent head and neck carcinoma

Classification by specialty

Oto-rhino-laryngology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

safety/efficacy

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

general condition
tumor marker
CT,MRI

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Single blind -participants are blinded

Control

Dose comparison

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

S-1

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >=

Gender

Male and Female

Key inclusion criteria

over 20 age and under 80 age

Key exclusion criteria

drug allergy history

Target sample size

50


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Torahiko Nakashima

Organization

Kyushu University

Division name

Otorhinolaryngology

Zip code


Address

3-1-1 Maidashi, Fukuoka

TEL

092-642-5668

Email

nakatora@qent.med.kyushu-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Ryuji Yasumatsu

Organization

Kyushu University

Division name

Otorhinolaryngology

Zip code


Address

3-1-1 Maidashi, Fukuoka

TEL

092-642-5668

Homepage URL


Email

yasuryuj@qent.med.kyushu-u.ac.jp


Sponsor or person

Institute

Department of ORL, Kyushu University

Institute

Department

Personal name



Funding Source

Organization

Department of ORL, Kyushu University

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2015 Year 05 Month 15 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2013 Year 08 Month 23 Day

Date of IRB


Anticipated trial start date

2015 Year 05 Month 20 Day

Last follow-up date

2016 Year 08 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2015 Year 05 Month 14 Day

Last modified on

2016 Year 11 Month 14 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000020363


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name